14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABVX.PA
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very red day for ABIVAX Société Anonyme stock price after a -8.07% fall in the Friday trading session
(Updated on Jun 14, 2024)

Sell candidate since Jun 13, 2024 Loss -8.07% PDF

The ABIVAX Société Anonyme stock price fell by -8.07% on the last day (Friday, 14th Jun 2024) from 12.88€ to 11.84€. During the last trading day the stock fluctuated 7.98% from a day low at 11.78€ to a day high of 12.72€. The price has risen in 6 of the last 10 days but is still down by -5.88% for this period. Volume has increased on the last day by 8 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 31 thousand shares were bought and sold for approximately 362.08€ thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at 11.35€ is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -7.96% during the next 3 months and, with a 90% probability hold a price between 10.45€ and 13.29€ at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ABVX.PA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ABIVAX Société Anonyme stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 12.79€ and 13.14€. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -22.00%. Further fall is indicated until a new bottom pivot has been found. ABIVAX Société Anonyme gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for ABIVAX Société Anonyme stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved 0.94€ (7.98%) between high and low. For the last week, the stock has had daily average volatility of 4.02%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ABVX.PA) For The Upcoming Trading Day Of Monday 17th

For the upcoming trading day on Monday, 17th we expect ABIVAX Société Anonyme to open at 12.11€, and during the day (based on 14 day Average True Range), to move between 11.39€ and 12.29€, which gives a possible trading interval of +/-0.454€ (+/-3.84%) up or down from last closing price. If ABIVAX Société Anonyme takes out the full calculated possible swing range there will be an estimated 7.67% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ 13.60€, some 1.76€ (14.86%) from the current price of 11.84€, our system finds the risk reward not very attractive.

Is ABIVAX Société Anonyme stock A Buy?

ABIVAX Société Anonyme holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.229 Sell Candidate Unchanged

Predicted Opening Price for ABIVAX Société Anonyme of Monday, June 17, 2024

Fair opening price June 17, 2024 Current price
12.11€ ( 2.31%) 11.84€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ABVX.PA

Fibonacci Support & Resistance Levels

Level Price
R3 13.05 10.25%
R2 12.69 7.21%
R1 12.47 5.34%
Price 11.84
S1 11.75 -0.724%
S2 11.53 -2.60%
S3 11.17 -5.63%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.76 24.66%
R2 13.82 16.72%
R1 13.60 14.86%
Price 11.84
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for ABIVAX Société Anonyme Stock and on which exchange is it traded?
The symbol for ABIVAX Société Anonyme is ABVX.PA and it is traded on the PAR (Euronext Paris).

Should I buy or sell ABIVAX Société Anonyme Stock?
ABIVAX Société Anonyme holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy ABIVAX Société Anonyme Stock?
ABIVAX Société Anonyme Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ABIVAX Société Anonyme Stock.

What's the current price of ABIVAX Société Anonyme Stock?
As of the end of day on the Jun 14, 2024, the price of an ABIVAX Société Anonyme (ABVX.PA) share was 11.84€.

What is the 52-week high and low for ABIVAX Société Anonyme Stock?
The 52-week high for ABIVAX Société Anonyme Stock is 19.18€ and the 52-week low is 7.91€.

What is the market capitalization of ABIVAX Société Anonyme Stock?
As of the Jun 14, 2024, the market capitalization of ABIVAX Société Anonyme is 744.943M.

When is the next earnings date for ABIVAX Société Anonyme?
The upcoming earnings date for ABIVAX Société Anonyme is Sep 09, 2024.
Click to get the best stock tips daily for free!

About ABIVAX Société Anonyme

ABIVAX Société Anonyme ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral ... ABVX.PA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT